Pharmaway Invest ApS — Credit Rating and Financial Key Figures

CVR number: 38585126
Fredskovvej 12 B, 2840 Holte

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-23.13-22.30-13.88-16.63-28.75
EBIT-23.13-22.30-13.88-16.63-28.75
Other financial expenses-2.27-2.84-3.68-2.95-9.83
Pre-tax profit-25.40-25.15-17.55-19.58-38.58
Net earnings-25.40-25.15-17.55-19.58-38.58

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Non-current loans receivable36 266.1848 240.5848 240.5848 240.5848 240.58
Long term receivables total36 266.1848 240.5848 240.5848 240.5848 240.58
Inventories total
Short term receivables total
Cash and bank deposits3.032.021.020.27
Cash and cash equivalents3.032.021.020.27
Balance sheet total (assets)36 266.1848 243.6248 242.6148 241.6148 240.85

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital55.0064.4564.4564.4564.45
Retained earnings36 059.6248 024.7647 999.6247 982.0647 962.49
Profit of the financial year-25.40-25.15-17.55-19.58-38.58
Shareholders equity total36 089.2248 064.0748 046.5248 026.9447 988.36
Non-current liabilities total
Current trade creditors4.384.384.384.3815.00
Current owed to participating210.29237.49
Current owed to group member172.59175.17191.71
Current liabilities total176.97179.55196.09214.67252.49
Balance sheet total (liabilities)36 266.1848 243.6248 242.6148 241.6148 240.85
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.